News

Yahoo Finance6mon
AOM Infusion Is Now a Limited Distribution Partner of ALYGLO™ Immunoglobulin Replacement Therapy
Patients treated with ALYGLO™ receive one infusion every three to four weeks administered by a nurse either at home or at an infusion center. GC Biopharma selected AOM Infusion as a partner ...
Yahoo Finance4mon
Advanced Infusion Care (AIC) now offers GC Biopharma’s ALYGLO™ [Immune Globulin Intravenous (Human-stwk) 10% liquid]
DALLAS, January 13, 2025--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured ... The nationally accredited home infusion teams at AIC collaborate closely ...
WNCT1y
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)
ALYGLO is a liquid solution containing 10% immunoglobulin G (100 mg/mL) for intravenous infusion, manufactured from pooled human plasma from US donors. The manufacturing process includes three ...
Oklahoma's News10mon
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited Distribution Partner for Partner of ALYGLO™ for Adults With Primary Humoral Immunodeficiency (PI)
July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA, Inc. as a limited distribution partner to provide ALYGLO ...
Mena FN10mon
Kabafusion Selected By GC Biopharma USA, Inc. As A Limited Distribution Partner For Partner Of ALYGLO™ For Adults With Primary Humoral Immunodeficiency (PI)
ALYGLO is a liquid solution containing 10% immunoglobulin G (100 mg/mL) for intravenous infusion. ALYGLO uses its novel proprietary Cation Exchange Chromatography (CEX) in the manufacturing ...